Who We Are
Servier & BioLabs
ABOUT SERVIER
Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2020, Servier employs 22,500 people worldwide. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups and biotech companies. It also integrates the patient's voice at the heart of its activities, from research to support beyond the pill. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology and immuno-inflammatory, and neurodegenerative diseases.
In 2023, Servier will open a R&D Institute with a startups incubator in the heart of the dynamic and innovative ecosystem of Paris-Saclay.
Crédit photo: @Wilmotte&Associates
ABOUT BIOLABS
BioLabs is a membership-based network of shared lab facilities located in key biotech innovation clusters, designed exclusively for high-potential, early-stage life science companies.
We offer co-working environments that pair premium, fully equipped and supported laboratory spaces with unparalleled access to capital and industry partners.
BioLabs operates facilities in the US and is actively working with partners on expansion projects in Europe, Asia and Australia.
Meet the Team
Olivier Nosjean
Head of Global Open Innovation and Scientific Affairs, R&D at Servier
Céline Triquel
Open R&D, Incubator Project Manager at Servier
SERVIER
BIOLABS
Philippe Guédon
Site Director BioLabs - Paris Saclay
Margaux Lesbats
Communication & Events Coordinator at BioLabs
Johanna Michielin
Head of BioLabs France
Hélène Sire
Senior Business Development Associate at BioLabs
Collaborations
Servier and BioLabs are collaborating beyond the Saclay Boston Biotech Masterclasses program, through various projects like the opening of a brand new startup incubator in Saclay and a series of conferences.
